RGNX
REGENXBIO Inc.Company with tickers: RGNX
CIK
1590877
CUSIP
75901B107
Shares Outstanding
51,697,621
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $89,012,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $53,087,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $12,127,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Net Income | $6,083,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $0.12 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $0.12 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |